|Abstract Notification||December 14, 2021**|
|January 20, 2021|
|Deadline to Make Changes to Title or Authors*||February 1, 2021|
|February 1, 2021**|
|Deadline to Upload Manuscript||March 15, 2021|
|Deadline for Self-Paced Presentation Upload||March 15, 2021|
|Deadline for Live Podium Presentation Upload||April 21, 2021|
|Speaker Ready Room Closes||April 21, 2021|
*Authors may only be added to an abstract if they have an existing author account in the abstract submission system and a completed COI Disclosure Form. Changes may NOT be made to the body of the abstract, images or tables. Sorry, no exceptions.
** Subject to change
Podium Presenter Requirements
Invitation and Confirmation
All podium presenters must confirm their participation by accepting their invitation(s) in the Speaker Management Site by January 20, 2021.
For assistance with username and passwords please contact the SRS Education Team at email@example.com or +1-414-289-9107.
Non-Exclusive License & Attestations
Non-Exclusive License and Attestations are to be completed in the Speaker Management Site by January 20, 2021.
The presenting author is required to register for the meeting and pay required registration fees by January 20, 2021.
A complete manuscript is required for the Whitecloud Award-Nominated Abstracts. The deadline to upload a manuscript is March 15, 2021. Manuscripts are uploaded to the Speaker Management Site. Manuscript guidelines can be downloaded below.
AV and Presentation Upload
Presentations can be uploaded to the Speaker Ready Room starting February 1, 2021. The Speaker Ready Room will close April 21, 2021, at 5:00 pm US Eastern Time.
Presentations should be in 16:9 format (widescreen). Click here for instructions on converting from 4:3 to 16:9.
Presenters who uploaded presentations to IMAST or last years Annual Meeting Speaker Ready Room may use the same email account and password. If you have forgotten your password, click the 'Forgot Password' button and it will be sent to the email account you used. Presenters who did NOT upload in 2018, 2019 or 2020 should create a new account the first time logging into the site. The SRS members-only site password, abstract submission site password, and M&M site password will NOT work. If you need further technical assistance, please click the "SUPPORT" button at the top right of the Speaker Ready Room homepage.
Abstracts will be published in the final program as originally submitted. Any corrections that need to be made to the title or author listing should be sent to firstname.lastname@example.org by February 1, 2021. SRS cannot make edits or additions to the abstract text. Also, authors may only be added to an abstract if they have an existing author account in the abstract submission system and a completed COI Disclosure Form.
Please note that all presentations must include a slide listing all of the author(s)' financial disclosures.
CME Accreditation Policies
Abstract presentations will be CME accredited, and it is therefore essential that they be free from commercial influence. References to particular commercial products must use their generic name or be balanced by referring to other similar products.
Product Name Use Policy
SRS strongly prefers that pharmaceuticals and proprietary software/databases as well as surgical approaches or specific instrumentation such as “Surgimap, MIMICS, EOS Imaging, ROTEM, Isola, TSRH, CD, XLIF, DLIF, AxiaLIF, Solera, Vertex, Expedium, Mountaineer, Shilla, VEPTR etc.,” are not used in presentations. These terms should be replaced by a generic term or description of the drug, software/database and/or instrumentation or technique unless the use of the term directly impacts learners’ understanding of the presentation or data. Instrumentation may also be referred to when the device name is a landmark system that is no longer sold (i.e. Harrington, Cotrel-Dubousset, Luque).
Company names and logos may not be used in any presentations (including in images).
It is recognized that studies evaluating a device or devices or comparing different devices or techniques may require the use of product or technique names. If a device trade name or industry developed technique using a trademarked name are used in an abstract or presentation, it will be specifically reviewed by the CME Committee for evaluation of any potential conflict of interest. When there is a known potential conflict of interest, an expanded verbal disclosure will be necessary at the time of presentation. Furthermore, if a product name is mentioned, the audience should be informed of why it is necessary to give the name.
Please notify us by emailing email@example.com if you plan to use a product name in your presentation.